Physician

Daniel Horton, M.D.

According to 2025 Medicare claims, Daniel Horton, M.D. (NPI: 1922091701) practices internal medicine in the Lynchburg, VA market, with the plurality of this provider's patient population coming from Lynchburg City, VA. This provider's primary affiliated billing organization is PRIVIA MEDICAL GROUP, LLC (NPI: 1013042480; TIN: 202265068) and primary practice location at 24501-2115. Horton is affiliated with the Privia Quality Network, LLC (ACO ID: A2057), participating under the MSSP model.

Horton's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 730 traditional Medicare patients, billed 15,375 HCPCS/CPT codes, and received $303,620 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 12,551 prescription claims across 1,037 beneficiaries totaling $1,085,479 in drug costs, led by Eliquis (Apixaban). DME data shows 812 claims. Open Payments data shows 3 records totaling $149. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $563,092 to $1,085,479. In contrast, DME billing represents a smaller volume and moved from a lower plateau to a higher plateau, from $10,595 to $62,560.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	698	9,589	$277,870
2016	701	11,363	$299,760
2017	760	10,348	$277,204
2018	756	11,071	$329,369
2019	798	11,278	$329,574
2020	835	10,689	$308,899
2021	891	10,829	$341,588
2022	710	10,016	$315,844
2023	668	11,440	$297,014
2024	730	15,375	$303,620

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	618	9,358	$563,092
2016	673	11,436	$693,047
2017	724	12,262	$711,683
2018	754	11,691	$736,677
2019	772	11,545	$827,873
2020	754	11,702	$864,283
2021	752	11,549	$953,986
2022	787	11,883	$1,026,275
2023	768	11,647	$1,166,285
2024	1,037	12,551	$1,085,479

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	63	253	$8,603
2016	101	376	$11,901
2017	171	513	$13,505
2018	239	836	$23,552
2019	245	755	$21,326
2020	236	659	$22,960
2021	287	749	$33,866
2022	285	803	$45,145
2023	277	829	$57,713
2024	274	812	$60,328

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	516	516	$125
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	612	1,219	$77
80061	Blood test, lipids (cholesterol and triglycerides)	541	714	$13
80053	Blood test, comprehensive group of blood chemicals	566	827	$10
36415	Insertion of needle into vein for collection of blood sample	581	990	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	150	9,380	$177,200
Ozempic	Semaglutide	93	4,768	$155,805
Trulicity	Dulaglutide	68	3,798	$123,687
Xarelto	Rivaroxaban	51	3,261	$60,444
Jardiance	Empagliflozin	33	3,030	$57,912

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	17	88	$35,957
A7031	Face mask interface, replacement for full face mask, each	N	14	47	$3,752
A7030	Full face mask used with positive airway pressure device, each	N	15	45	$3,250
A7032	Cushion for use on nasal mask interface, replacement only, each	N	15	35	$2,917
A7034	Nasal interface (mask or cannula type) used with positive airway pressure device, with or without head strap	N	26	58	$2,794

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	3	$149	InSightec,Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Daniel Horton, M.D.?

Tedicare shows public-source Medicare data for Daniel Horton, M.D. (NPI 1922091701), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Daniel Horton, M.D. have ACO affiliation data?

Daniel Horton, M.D. is shown with ACO affiliation data for Privia Quality Network, LLC (MSSP, ACO ID A2057).

What billing organization is linked to Daniel Horton, M.D.?

Daniel Horton, M.D. is linked to PRIVIA MEDICAL GROUP, LLC (billing NPI 1013042480) in the available physician profile data.

Does Daniel Horton, M.D. have Open Payments data?

Daniel Horton, M.D. has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.